November 11, 2025

ED drugs tied to lower gastric cancer risk

Large retrospective study finds 30% reduction in gastric malignancy among men taking erectile dysfunction medications.

Conexiant

November 11, 2025

Scrotal Surgery Risk After Kidney Donation

Population study reveals about 1 in 8 male donors require surgery within 20 years—nearly 40 times the rate of matched controls.

Conexiant

November 05, 2025

SGLT2 Inhibitors Reduce Lung Cancer Surgery

Patients with diabetes taking SGLT2 inhibitors show fewer lung surgeries over 10 years.

Conexiant

November 04, 2025

Why Do Women Need Less Exercise for the Same Heart Benefit?

Accelerometer data from over 85,000 UK Biobank participants reveal significant sex differences in physical activity benefits for heart disease prevention and survival.

Conexiant

November 04, 2025

Should SGLT-2 Inhibitors Be Continued After a UTI?

Patients with type 2 diabetes who developed urinary tract infections while taking sodium-glucose cotransporter-2 inhibitors faced higher heart and kidney risks.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 27, 2025

Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors

"There's no such thing as a routine colonoscopy. Every colonoscopy has a potential for mistakes."

Conexiant

October 24, 2025

A New Approach to Lowering Cardiovascular Risk?

Researchers evaluated obicetrapib’s effects on lipid levels and cardiovascular outcomes.

Conexiant

October 23, 2025

Waist Loss Only Part of Semaglutide’s Power

Semaglutide lowered cardiovascular events in patients with overweight or obesity without diabetes, independent of weight loss.

Conexiant